Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BURU ENERGY LIMITED Proxy Solicitation & Information Statement 2025

Oct 16, 2025

64565_rns_2025-10-16_cd3d535e-690c-4359-8f5d-06e049f792e4.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

==> picture [596 x 110] intentionally omitted <==

17 October 2025

Dear Shareholder

Notice is given that the General Meeting ("Meeting") of Buru Energy Limited (“Buru Energy” or “Company”) will be held as follows:

TIME: 9.00 am (Perth time) DATE: Tuesday, 18 November 2025 PLACE: The Park Business Centre, 45 Ventnor Avenue, West Perth WA 6005

NOTICE OF MEETING

As with previous years, Buru Energy will not be posting hard copies of the Notice of Meeting and personalised proxy forms to shareholders who have not elected to receive notices electronically. Instead:

  • the Notice of Meeting which sets out the Agenda (including details of all resolutions being put to the meeting), important Voting Information and an Explanatory Memorandum can be viewed on, or downloaded from, the Company's website at https://buruenergy.com/announcements or the Company's ASX announcements page at www.asx.com.au; and

  • your personalised proxy form is enclosed with this letter.

Buru Energy shareholders who have elected to receive electronic communications from the Company have received, or will shortly receive, an email containing instructions about how to view or download a copy of the Notice of Meeting (or request a hard copy of it), as well as instructions on how to lodge their proxies.

Any Buru Energy shareholder who would like to obtain a free paper copy of the Notice of Meeting can request a copy by contacting Buru Energy on [email protected].

Please refer to the Notice of Meeting for further important information.

PROXY LODGEMENTS

Shareholders who choose to lodge a proxy should follow instructions on their personalised proxy form (enclosed), to be submitted to Buru Energy’s share registry by no later than 9.00 am (Perth time) on Sunday, 16 November 2025 online, by facsimile or by post.

Yours sincerely

==> picture [110 x 36] intentionally omitted <==

David Maxwell Chair

Buru Energy Limited, Level 2, 16 Ord Street, West Perth WA 6005 Telephone: 1800 337 330 Email: [email protected] ABN: 71 130 651 437

==> picture [596 x 111] intentionally omitted <==

BURU ENERGY LIMITED ABN 71 130 651 437

NOTICE OF GENERAL MEETING

TIME: 9.00 am (AWST) DATE: Tuesday, 18 November 2025 PLACE: The Park Business Centre, 45 Ventnor Avenue, West Perth WA 6005

This Notice of Meeting should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their professional advisers prior to voting. The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at 9.00am (AWST) on 16 November 2025.

NOTICE OF GENERAL MEETING

Notice is given that a General Meeting (the Meeting ) of Shareholders of Buru Energy Limited ABN 71 130 651 437 (the Company ) will be held at The Park Business Centre, 45 Ventnor Avenue, West Perth WA on Tuesday, 18 November 2025 at 9.00 am (AWST).

PROPOSED RESOLUTIONS

1. Resolution 1 – Ratification of prior issue of Shares

To consider and, if thought fit, pass the following as an ordinary resolution :

“That, for the purposes of Listing Rule 7.4, and for all other purposes, Shareholders ratify the issue of 105,000,000 Shares to Placement Participants, on the terms and conditions set out in the Explanatory Notes.”

2. Resolution 2 – Approval to issue Options to Placement Participants

To consider and, if thought fit, pass the following as an ordinary resolution:

“That, for the purposes of Listing Rule 7.1 and all other purposes, approval is given for the Company to issue up to 52,500,000 Options to the Placement Participants (or their nominees), on the terms and conditions set out in the Explanatory Notes.”

3. Resolution 3 – Approval to issue Options to SPP Participants

To consider and, if thought fit, pass the following as an ordinary resolution:

“That, for the purposes of Listing Rule 7.1 and all other purposes, approval is given for the Company to issue up to 57,575,000 Options to SPP Participants (or their nominees) and investors issued shortfall Shares under the SPP, on the terms and conditions set out in the Explanatory Notes.”

4. Resolution 4 – Ratification of prior issue of incentive Performance Rights

To consider and, if thought fit, pass the following as an ordinary resolution:

“That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 3,870,000 incentive Performance Rights to the Employees, on the terms and conditions set out in the Explanatory Notes.”

5. Resolution 5 – Approval to issue Options to Mr David Maxwell

To consider and, if thought fit, pass the following as an ordinary resolution:

“That, for the purposes of Listing rule 10.11 and for all other purposes, Shareholders approve the issue of up to 750,000 Options to Mr David Maxwell (or his nominees), on the terms and conditions set out in the Explanatory Notes.”

Page | 1

Chair's voting intention: The Chair of the Meeting (where appropriately authorised) intends to vote all available undirected proxies in favour of Resolutions 1,2,3,4 and 5.

By order of the Board

==> picture [67 x 33] intentionally omitted <==

Paul Bird

Chief Financial Officer and Company Secretary

17 October 2025

Page | 2

VOTING EXCLUSIONS FOR THE RESOLUTIONS

1. Resolution 1 – Ratification of prior issue of Shares to Placement Participants issued under Listing Rule 7.1

Voting Exclusion

The Company will disregard any votes cast in favour of Resolution 1 by or on behalf of:

  • (a) a person who participated in the issue of shares under the Placement; or

  • (b) an associate of that person or those persons.

However, this does not apply to a vote cast in favour of the Resolution by:

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

2. Resolution 2 – Approval to issue Options to Placement Participants

Voting Exclusion

The Company will disregard any votes cast in favour of Resolution 2 by or on behalf of:

  • (a) a person who participated in the Placement; or

  • (b) an associate of that person or those persons.

However, this does not apply to a vote cast in favour of the Resolution by:

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

Page | 3

3. Resolution 3 – Approval to issue Options to SPP Participants

Voting Exclusion

The Company will disregard any votes cast in favour of Resolution 3 by or on behalf of:

  • (a) a person who participated in the SPP (or were issued shortfall Shares under the SPP); or

  • (b) an associate of that person or those persons.

However, this does not apply to a vote cast in favour of the Resolution by:

  • (c) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or

  • (d) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (e) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

4. Resolution 4 – Ratification of prior issue of incentive Performance Rights

Voting Exclusion

The Company will disregard any votes cast in favour of Resolution 4 by or on behalf of:

  • (a) a person who participated in the issue of Performance Rights issued under Listing Rule 7.1; or

  • (b) an associate of that person or those persons.

However, this does not apply to a vote cast in favour of the Resolution by:

  • (c) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or

  • (d) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (e) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

Page | 4

5. Resolution 5 – Approval to issue Options to Mr David Maxwell

Voting Exclusion

The Company will disregard any votes cast in favour of Resolution 5 by or on behalf of Mr David Maxwell and any other person who will obtain a material benefit as a result of the issue contemplated by Resolution 5 (except a benefit solely by reason of being a holder of ordinary securities in the Company) or an associate of that person or those persons.

However, this does not apply to a vote cast in favour of the Resolution by:

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

Page | 5

VOTING AND ATTENDANCE INFORMATION

Right to vote

As set out on the cover page of this Notice of Meeting, the Board has determined that persons who are registered as Shareholders as at 9.00am (AWST) on Sunday, 16 November 2025 will be entitled to attend and vote at the Meeting.

If more than one joint holder of Shares is present at the Meeting (whether personally or by proxy, attorney or representative) and tenders a vote, only the vote of the joint holder whose name appears first on the register will be counted.

How to vote

Voting in person

To vote in person, attend the Meeting at the date, time and place set out above.

If you attend the Meeting, please bring your personalised proxy form with you to assist with registration. If you do not bring your form with you, you will still be able to attend the Meeting, but you will need to verify your identity.

Voting by proxy

If you are a Shareholder entitled to attend and vote at the Meeting, you may appoint an individual or a body corporate as a proxy. A personalised Proxy Form accompanies this Notice of Meeting. A proxy need not be a Shareholder.

If a body corporate is appointed as a proxy, that body corporate must ensure that it appoints a corporate representative in accordance with section 250D of the Corporations Act to exercise its powers as proxy at the Meeting.

A Shareholder may appoint up to two proxies and specify the proportion or number of votes each proxy may exercise. If the Shareholder does not specify the proportion or number of votes to be exercised, each proxy may exercise half of the Shareholder’s votes.

The Corporations Act provides that if proxy holders vote, they must cast all directed proxies as directed, and any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies as directed. If the proxy has two or more appointments that specify different ways to vote on the resolution, the proxy must not vote on a show of hands.

To vote by proxy, the Proxy Form must be completed, signed and returned to the Share Registry in accordance with the methods set out below, so that it is received at least 48 hours before the Meeting (that is, by no later than 9.00am (AWST) on Sunday, 16 November 2025 ( Proxy Deadline )):

By post: Buru Energy Limited
C/- MUFG Corporate Markets (AU) Limited
A division of MUFG Pension & Markets Services
Locked Bag A14
Sydney South NSW 1235
By facsimile: +61 2 9287 0303
By delivery: MUFG Corporate Markets (AU) Limited
A division of MUFG Pension & Markets Services
Level 41
161 Castlereagh St
Sydney NSW 2000.

Page | 6

Proxy Forms received after the Proxy Deadline will be invalid.

Voting online

You can also vote online at https://au.investorcentre.mpms.mufg.com.To vote online, select "Investor Login" and enter Buru Energy Limited or the ASX code BRU in the Issuer name field, your Securityholder Reference Number (SRN) or Holder Identification Number (HIN) (which is shown on the front of your Proxy Form), enter your postcode (Australian address) or country (overseas address), complete the security validation process and security code which is shown on the screen and click ‘Login’. Select the "Voting" tab and then follow the prompts. You will be taken to have signed and returned your Proxy Form if you vote online in accordance with the instructions given on the website. If you choose to vote online, you must vote by the Proxy Deadline.

Voting by attorney

If a Shareholder has appointed an attorney to attend and vote at the Meeting, or if the Proxy Form is signed by an attorney, the power of attorney (or a certified copy of the power of attorney) under which the Proxy Form is signed must be sent using one of the methods listed above for the receipt of Proxy Forms and received by the Company before the Proxy Deadline (unless this document has previously been lodged with the Company's Share Registry for notation).

Corporate representatives

A body corporate that is a Shareholder, or that has been appointed as a proxy, is entitled to appoint a person to act as its representative at the Meeting. The appointment of the representative must comply with the requirements under section 250D of the Corporations Act. The representative should bring to the Meeting evidence of his or her appointment as the body corporate's representative, including any authority under which the appointment is signed.

Shareholders can download and fill out the "Appointment of Corporate Representation" form from the MUFG website: https://www.mpms.mufg.com/media/ewkhj1g0/app_corp_rep.pdf

Shareholder questions

Shareholders are encouraged to submit written questions in advance of the Meeting, please email your question to the Company Secretary at [email protected].

To allow time to collate questions and prepare answers, questions must be received by the Company Secretary by 5.00 pm (AWST) on Friday, 14 November 2025.

We will endeavour to respond to as many of the more frequently asked questions as possible at the Meeting.

Page | 7

EXPLANATORY NOTES

These Explanatory Notes form part of the Notice of Meeting and provide information to Shareholders about the items of business to be considered at the Meeting.

The Directors recommend that Shareholders read these Explanatory Notes, together with the Notice of Meeting, in their entirety before deciding how to vote in respect of the Resolutions.

Terms and abbreviations used in this Notice of Meeting are defined in Schedule 1 to this Notice of Meeting (or elsewhere in the body of this Notice of Meeting).

AGENDA

1. Resolutions 1, 2 and 3

1.1 Overview

On 1 September 2025, the Company announced a capital raising comprising:

  • (a) a placement to raise $2,100,000 before costs by the issue of 105,000,000 Shares to sophisticated and professional investors ( Placement Participants ) at $0.02 each ( Placement ); and

  • (b) an offer under a share purchase plan to eligible Shareholders ( SPP Participants ) to raise up to $3,000,000 before costs (with the ability to accept oversubscriptions) by the issue of up to 150,000,000 Shares at an issue price of $0.02 each ( SPP ).

Under the SPP, SPP Participants were each entitled to apply for up to $30,000 worth of Shares. The SPP was completed on 7 October 2025.

The Company issued 105,000,000 Shares pursuant to the Placement on 5 September 2025 ( Placement Date ), utilising the Company's placement capacity under Listing Rule 7.1.

The Company engaged the services of Wilsons Advisory ( Wilsons ) and Evolution Capital ( Evolution ) to act as joint lead managers in respect of the Placement. In consideration for their services provided in connection with the Placement, the Company agreed to pay Wilsons and Evolution an aggregate fee of up to 6% of the total amount raised under the Placement. The agreement with the joint lead managers is otherwise on terms considered standard for an agreement of its nature.

116,650,000 Shares were issued under the SPP (including those issued to investors who applied for shortfall Shares under the SPP on 14 October 2025, pursuant to ASIC Corporations (Share and Interest Purchase Plans) Instrument 2019/ 547 ( Instrument ).

SPP Participants and Placement Participants (as well as investors who applied for shortfall Shares under the SPP) were offered 1 free attaching option to acquire a Share ( Option ) for every 2 Shares issued, subject to Shareholder approval. Each Option has an exercise price of $0.03 and will expire 2 years from the date of issuance. The issue of all of the Options is subject to Shareholder approval. If approved, the issue of the Options is anticipated for 25 November 2025.

A copy of the Company's announcement to ASX on 1 September 2025 is available on the Company's website: https://buruenergy.com/announcements/7132615 and the website of ASX (at www.asx.com.au).

Resolution 1 seeks Shareholder ratification for the issue of Shares to the Placement Participants, the subject of the Placement, pursuant to Listing Rule 7.4

Resolution 2 seeks Shareholder approval for the issue of up to 52,500,000 Options to the Placement Participants (or their nominees) under the Placement, pursuant to Listing Rule 7.1.

Resolution 3 seeks Shareholder approval for the issue of 57,575,000 Options to the SPP Participants (or their nominees) (including the issue of shortfall Shares under the SPP) under the SPP, pursuant to Listing Rule 7.1.

Page | 8

1.2 Listing Rules 7.1 and 7.4

Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of Equity Securities that a listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid ordinary securities it had on issue at the start of that period.

The Placement does not fit within any of the exceptions set out in Listing Rule 7.2 and, as it has not yet been approved by the Company's Shareholders, the Placement, effectively uses up part of the Company’s 15% limit available under Listing Rule 7.1, reducing the Company's capacity to issue further Equity Securities without Shareholder approval under Listing Rules 7.1 for the 12 month period following the Placement Date.

Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of Equity Securities after it has been made or agreed to be made. If they do, the issue is taken to have been approved under Listing Rule 7.1 and so does not reduce the Company's capacity to issue further Equity Securities without shareholder approval under that rule.

The Company wishes to retain as much flexibility as possible to issue additional Equity Securities into the future without having to obtain Shareholder approval for such issues under Listing Rule 7.1.

To this end, for the purposes of Listing Rule 7.4, Resolution 1 seeks to ratify the issue of Shares to the

Placement Participants.

If Resolution 1 is passed, the Shares issued under the Placement will be excluded in calculating the Company's 15% limit in Listing Rule 7.1 effectively increasing the number of Equity Securities, it can issue without Shareholder approval over the 12 month period following the Placement Date.

If Resolution 1 is not passed, the Shares issued under the Placement will be included in calculating the Company's 15% limit in Listing Rule 7.1 effectively decreasing the number of Equity Securities, it can issue without Shareholder approval over the 12 month period following the Placement Date.

The proposed issue of Options to the Placement and SPP Participants (including the issue of shortfall Shares under the SPP) (or their nominees) fall under exception 17 of Listing Rule 7.2. They therefore require the approval of Shareholders under Listing Rule 7.1. Resolution 2 seeks Shareholder approval for the issuance of the Options to Placement Participants (or their nominees) and Resolution 3 seeks Shareholder approval for the issuance of Options to the SPP Participants (or their nominees) and investors issued shortfall Shares under the SPP.

If Resolution 2 is passed, the Company will make an issue of Options to the Placement Participants (or their nominees). In addition, the issue of the Options will be excluded from the calculation of the number of equity securities that the Company can issue without Shareholder approval under Listing Rule 7.1.

If Resolution 2 is not passed, the Company will not be able to proceed with the issuance of the Options to the Placement Participants (or their nominees). Consequently, the Company may be in breach of the relevant placement agreements and may be required to pay the cash equivalent of the Options to the Placement Participants.

If Resolution 3 is passed, the Company will make an issue of Options to SPP Participants (or their nominees) and investors issued shortfall Shares under the SPP. In addition, the issue of the Options will be excluded from the calculation of the number of equity securities that the Company can issue without Shareholder approval under Listing Rule 7.1.

If Resolution 3 is not passed, the Company will not be able to proceed with the issuance of the Options to the SPP Participants (or their nominees) who participated in the SPP, and investors issued shortfall Shares under the SPP.

1.3 Information required by Listing Rule 7.5 for Resolution 1

In accordance with Listing Rule 7.5, the Company provides the following information:

  • (a) The Shares were issued to the Placement Participants, comprising institutional, professional and sophisticated investors who were clients of Wilsons and Evolution, other broking houses and existing long term Shareholders. The recipients were identified through a bookbuild process, which

Page | 9

involved Wilsons and Evolution or the Company seeking expressions of interest to participate in the Placement from non-related parties of the Company.

In accordance with paragraph 7.4 of Guidance Note 21, the Company confirms that none of the recipients were:

  • related parties of the Company, a member of the Company's key management personnel, a substantial holder in the Company, an adviser to the Company or an associate of any of these parties; and

  • issued more than 1% of the issued capital of the Company.

  • (b) 105,000,000 Shares were issued pursuant to Listing Rule 7.1 (ratification of which is sought under Resolution 1).

  • (c) The Shares were issued on the Placement Date (i.e. 5 September 2025).

  • (d) The issue price was $0.02 per Share. The Company has not and will not receive any other consideration for the issue of the Shares.

  • (e) The purpose of the Placement was to raise new funds, which are to be applied towards the commercialisation of the Rafael Gas Project, supporting the farm-out of the Mars oil prospect which may also underpin a restart of production at the Ungani Oilfield, and for general working capital purposes (including associated costs of the Placement).

  • (f) The Shares were not issued under an agreement.

  • (g) A voting exclusion statement for Resolution 1 is included in the Notice of Meeting preceding these Explanatory Notes.

  • (h) The issue of the Shares did not breach Listing Rule 7.1.

1.4 Information required by Listing Rule 7.3 for Resolutions 2 and 3

Pursuant to and in accordance with the requirements of ASX Listing Rule 7.3, the following information is provided in relation to Resolutions 2 and 3:

  • (a) the Options are to be allotted to SPP and Placement Participants who participated in the Placement and/or SPP; (and investors issued shortfall Shares under the SPP), none of whom are:

  • related parties of the Company, a member of the Company's key management personnel, a substantial holder in the Company, an adviser to the Company or an associate of any of these parties; and

  • Mr William Richmond was issued 47,500,000 Shares as a result of their participation in the shortfall offered under the SPP, which represents a holding of approximately 4.74% of the issued capital of the Company.

  • (b) The maximum number of Options to be issued is 110,825,000, being 52,500,000 Options pursuant to the Placement and 57,575,000 pursuant to the SPP (or via the issue of shortfall shares under the SPP).

  • (c) The material terms of the Options are set out in Schedule 2 of this Notice of Meeting.

  • (d) The Options are expected to be issued within five business days of the Meeting but in any event, not more than three months after Shareholder approval;

  • (e) The Options are being issued as attaching options under the Placement and SPP and, accordingly, the issue price for them is nil.

Page | 10

  • (f) The Options are being issued as attaching options under the Placement and SPP for nil upfront consideration to incentivise participation in the Placement and SPP and, therefore, do not raise funds for the Company at the time of issue of the Options. Any funds raised from the exercise of the Options will be used to support the Company’s activities associated with the Rafael Project and otherwise for general working capital purposes.

  • (g) The Options are not being issued under an agreement.

  • (h) A voting exclusion statement for each of Resolutions 2 and 3 is included in the Notice of Meeting preceding these Explanatory Notes.

1.5 Board recommendation

Although no decision has been made by the Board to undertake any future issue of Shares, the Board considers it prudent for the Company to retain as much flexibility as possible to issue additional Shares into the future without having to obtain Shareholder approval for such issues under Listing rule 7.1. As such, the Board believes that Resolution 1 is in the best interests of the Company and its Shareholders, and unanimously recommends that Shareholders vote in favour of the Resolution 1.

The Company has made representations to Shareholders who participated in the Placement and SPP, that would entitle them to receive free attaching Options, the Board therefore recommends that Shareholders vote in favour of Resolutions 2 and 3.

2. Resolution 4 – Ratification of prior issue of incentive Performance Rights

2.1 Overview

On 23 January 2025 the Company issued 3,870,00 Performance Rights under the Company’s Employee Incentive Performance Rights Plan ( Plan ) to employees of the Company.

These Performance Rights consist of the following:

Class Number
of
Performance
Rights
Basis Vesting Issued to
A 1,935,000 Service Based 1 July 2025 Staff
B 1,935,000 Service Based 1 July 2026 Staff

A copy of the Company's announcement to ASX on 23 January 2025 is available on the Company's website: https://buruenergy.com/announcements/6760855 and the website of ASX (at www.asx.com.au).

2.2 Listing Rules 7.1 and 7.4

Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of Equity Securities that a listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid ordinary securities it had on issue at the start of that period.

The issue of the Performance Rights does not fit within any of the exceptions set out in Listing Rule 7.2, as it has not yet been approved by the Company's Shareholders, it effectively uses up part of the Company’s 15% limit available under Listing Rule 7.1, reducing the Company's capacity to issue further Equity Securities without Shareholder approval under Listing Rules 7.1 for the 12 month period following the Placement Date.

Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of Equity Securities after it has been made or agreed to be made. If they do, the issue is taken to have been approved under Listing Rule 7.1 and so does not reduce the Company's capacity to issue further Equity Securities without shareholder approval under that rule.

The Company wishes to retain as much flexibility as possible to issue additional Equity Securities into the future without having to obtain Shareholder approval for such issues under Listing Rule 7.1.

Page | 11

To this end, Resolution 4 seeks Shareholder ratification of the issue of the Performance Rights under the Plan and for the purposes of Listing Rule 7.4.

If Resolution 4 is passed, the issue of the Performance Rights will be excluded in calculating the Company's 15% limit under Listing Rule 7.1 effectively increasing the number of Equity Securities, it can issue without Shareholder approval over the 12 month period following the issue of the Performance Rights.

If Resolution 4 is not passed, the issue of the Performance Rights will be included in calculating the Company's 15% limit under Listing Rule 7.1, effectively decreasing the number of Equity Securities, it can issue without Shareholder approval over the 12 month period following the issue of the Performance Rights.

2.3 Information required by Listing Rule 7.5

In accordance with Listing Rule 7.5, the Company provides the following information:

  • (a) The Performance Rights were issued to key management personnel and staff (together, the Employees) under the Plan.

  • (b) The terms and conditions of the Performance Rights are detailed in Schedule 3.

  • (c) 560,000 Performance Rights were issued to Paul Bird (Chief Financial Officer and Company Secretary), no other key management personnel received Performance Rights.

  • (d) A total of 3,870,000 Performance Rights were issued.

  • (e) The Performance Rights were issued on 23 January 2025.

  • (f) The Performance Rights were issued for nil cash consideration

  • (g) No funds were raised from the issue of the Performance Rights as the Performance Rights were issued as part of the remuneration arrangements with employees of the Company.

  • (h) The Performance Rights were not issued under an agreement.

  • (i) A voting exclusion statement for Resolution 4 is included in the Notice of Meeting preceding this Explanatory Notes.

  • (j) The issue of the Performance Rights did not breach Listing Rule 7.1.

2.4 Board recommendation

The Board recommends that Shareholders vote in favour of Resolution 4.

3. Resolution 5 - Approval to issue Options to Mr David Maxwell

3.1

Overview

The Company previously announced the intention that Mr David Maxwell (Non-Executive Chair) would participate in the SPP. Mr Maxwell as an eligible Shareholder subscribed for and was issued 1,500,000 Shares on the terms and conditions set out in the SPP. Mr Maxwell therefore has the right under the SPP to apply for 750,000 Options (Director Attaching Options) on the terms and conditions set out in the Explanatory Notes and Mr Maxwell plans to exercise this right

Regulatory Requirements

Listing Rule 10.11 provides that, unless a specified exception set out at Listing Rule 10.12 applies, a company must not issue or agree to issue Equity Securities to a related party (amongst others) without the approval of its ordinary shareholders. A “related party” includes the directors of a company. The issue of the Director Attaching Options does not fall under an exception to Listing Rule 10.12.

As such, Shareholder approval is sought in respect of the issue of the Director Attaching Options to Mr David Maxwell under Resolution 5, for the purpose of Listing Rule 10.11 and all other purposes, by virtue of his directorships.

As Shareholder approval is being sought under Listing Rule 10.11, approval is not required under Listing Rule 7.1, and the issue of the Director Attaching Options (if approved) will not impact the 15% Placement Capacity or the Additional 10% Placement Capacity.

Page | 12

As Shareholder approval is being sought under Listing Rule 10.11, approval is not required under Listing Rule 7.1, and the issue of the Director Attaching Options (if approved) will not impact the 15% Placement Capacity or the Additional 10% Placement Capacity.

If Resolution 5 is passed, Mr Maxwell will be issued the Director Attaching Options on the terms and conditions set out in the Explanatory Notes.

If Resolution 5 is not passed, Mr Maxwell will not be issued the Director Attaching Options.

Technical information required by Listing Rule 10.13

Pursuant to and in accordance with Listing Rule 10.13, the following information is provided in relation to Resolution 5:

  • (a) The Director Attaching Options to be issued under Resolution 5 are to be issued to Mr David Maxwell (or his nominee).

  • (b) Mr Maxwell is a Director and therefore, related party of the Company, and as such, is a person who falls within the category of persons in a position of influence contemplated in Listing Rule 10.11.1.

  • (c) A total of 750,000 Director Attaching Options will be issued to Mr David Maxwell (or his nominee) if Resolution 5 is approved by Shareholders. on the terms and conditions set out in Schedule 2.

  • (d) The Company will issue the Director Attaching Options if approved, as soon as possible and in any event within one month after the date of the Meeting.

  • (e) The Director Attaching Options will be issued for nil consideration on the terms and conditions set out in the Explanatory Notes.

  • (f) The purpose of the issue of the Director Attaching Options is to allow Mr Maxwell, as an eligible Shareholder to participate in the SPP on the same terms as the unrelated SPP Participants.

  • (g) The Director Attaching Options are being issued as attaching Options under the SPP for nil upfront consideration and, therefore, will not raise funds for the Company. Any funds raised from the exercise of the Director Attaching Options will be used to support the Company’s activities associated with the Rafael Project and otherwise for general working capital purposes.

  • (h) The Director Attaching Options are not being issued to incentivise Mr Maxwell.

  • (i) The Director Attaching Options are not being issued under an agreement.

  • (j) A voting exclusion statement for Resolution 5 is included in the Notice of Meeting preceding this Explanatory Statement.

3.3 Chapter 2E – Corporations Act

For a public company, or an entity that the public company controls, to give a financial benefit to a related party of the public company, the public company or entity must:

  • (a) obtain the approval of the public company’s members in the manner set out in sections 217 to 227 of the Corporations Act; and

  • (b) give the benefit within 15 months following such approval, unless the giving of the financial benefit falls within an exception set out in sections 210 to 216 of the Corporations Act.

Mr Maxwell’s participation in the SPP will result in the issue of Director Attaching Options which constitutes giving a financial benefit and Mr Maxwell is a related party of the Company by virtue of being a Director.

The Directors (other than Mr Maxwell who has a material personal interest in Resolution 5) consider that Shareholder approval pursuant to Chapter 2E of the Corporations Act is not required in respect of their

Page | 13

participation because the Director Attaching Options will be issued to Mr Maxwell (or his respective nominees) on the same terms as the Attaching Options issued to non-related participants in the Placement and SPP, and as such the giving of the financial benefit is on arm’s length terms.

3.4 Board Recommendation

Each Director (other than Mr Maxwell), who abstains by reason of his material personal interest in the outcome of Resolution 5) recommends that Shareholders vote in favour of Resolution 5.

Page | 14

Schedule 1 – Definitions

Term Meaning
ASX ASX Limited (ABN 98 008 624 691) or the financial market conducted by it (the
Australian Securities Exchange), as the context requires.
AWST Australian Western Standard Time.
Board The board of Directors of the Company.
Chair The chair of the Meeting appointed in accordance with the Constitution.
Closely Related Party Closely Related Party of a member of the Key Management Personnel means:

a spouse or child of the member; or

a child of the member's spouse; or

a dependant of the member or of the member's spouse; or

anyone else who is one of the member's family and may be expected to influence
the member, or be influenced by the member, in the member's dealings with the
Company; or

a company that the member controls; or

a person prescribed by the_Corporation Regulations 2001_(Cth).
Company Buru Energy Limited (ABN 71 130 651 437).
Constitution The constitution of the Company.
Corporations Act Corporations Act 2001(Cth).
Director A director of the Company.
Director Attaching
Options
750,000 Options applied for by a Director pursuant to the offer made under the SPP.
Eligible Entity Has the meaning given to that term in the Listing Rules.
Employee
Performance Rights
Employee Performance Rights issued under the Employee Incentive Performance
Rights Plan.
Employee Incentive
Performance Rights
Plan
As detailed in schedule 3.
Equity Securities Has the meaning given to that term in the Listing Rules.
Explanatory Notes The explanatory notes enclosed with and forming part of this Notice.
General Meeting or
Meeting
The general meeting of the Company notified to Shareholders by this Notice.
Guidance Note The guidance notes accompanying the Listing Rules, as amended or waived from time
to time.

Page | 15

Key Management
Personnel or KMP
Has the same meaning as in the accounting standards. The term broadly includes
those persons with the authority and responsibility for planning, directing and controlling
the activities of the Company (whether directly or indirectly), and includes any Director
of the Company.
Listing Rule The official listing rules of ASX, as amended or waived from time to time.
Notice of Meetingor
Notice
This notice of meeting incorporating the Explanatory Notes and the Proxy Form.
Placement Share placement announced on 1 September 2025
Placement
Participants
Shareholders who participated in the Placement.
Proxy Form The proxy form enclosed with and forming part of this Notice.
Resolution A resolution referred to in this Notice.
Share A fully paid ordinary share in the capital of the Company.
Share Registry MUFG Corporate Markets (AU) Limited.
Shareholder A registered holder of a Share.
SPP Share Purchase Plan as announced on 1 September 2025
SPP Participants Shareholders who participated in the SPP.
$ A reference to "$" is to Australian currency.

Page | 16

Schedule 2 –Options Terms

1. Entitlement Each Option entitles the holder to subscribe for one Share upon
exercise of the Option.
2. Exercise Price Subject to paragraph 9, the amount payable upon exercise of each
Option will be $0.03 (Exercise Price).
3. Expiry Date Each Option will expire at 5:00 pm (AWST) on the date that is 2 years
from the date of issue (Expiry Date).
An Option not exercised before the Expiry Date will automatically
lapse on the Expiry Date
4. Exercise Period The Options are exercisable at any time on or prior to the Expiry Date
(Exercise Period).
5. Exercise Notice The Options may be exercised during the Exercise Period by notice in
writing to the Company in the manner specified on the Option
certificate (Exercise Notice) and payment of the Exercise Price for
each Option being exercised in Australian currency by electronic
funds transfer or other means of payment acceptable to the
Company.
6. Exercise Date An Exercise Notice is only effective on and from the later of the date
of receipt of the Exercise Notice and the date of receipt of the
payment of the Exercise Price for each Option being exercised in
cleared funds (Exercise Date).
7. Timing of issue of
Shares on exercise
Within five Business Days after the Exercise Date, the Company will:
(a)
issue the number of Shares required under these terms and
conditions in respect of the number of Options specified in
the Exercise Notice and for which cleared funds have been
received by the Company;
(b)
if required, give ASX a notice that complies with section
708A(5)(e) of the Corporations Act, or, if the Company is
unable to issue such a notice, lodge with ASIC a prospectus
prepared in accordance with the Corporations Act and do
all such things necessary to satisfy section 708A(11) of the
Corporations Act to ensure that an offer for sale of the
Shares does not require disclosure to investors; and
(c)
if admitted to the official list of ASX at the time, apply for
official quotation on ASX of Shares issued pursuant to the
exercise of the Options.
If a notice delivered under 7(b) for any reason is not effective to
ensure that an offer for sale of the Shares does not require disclosure
to investors, the Company must, no later than 20 Business Days after
becoming aware of such notice being ineffective, lodge with ASIC a
prospectus prepared in accordance with the Corporations Act and
do all such things necessary to satisfy section 708A(11) of the
Corporations Act to ensure that an offer for sale of the Shares does
not require disclosure to investors.
8. Shares issued
on exercise
Shares issued on exercise of the Options rank equally with the then
issued shares of the Company.
9. Reorganisation If there is a reorganisation of the issued share capital of the Company
(including any subdivision, consolidation, reduction, return or
cancellation of such issued capital of the Company),the rights of the

Page | 17

holder will be changed to the extent necessary to comply with the
ASX Listing Rules applicable to a reorganisation of capital at the time
of the reorganisation.
10. Participation in
new issues
There are no participation rights or entitlements inherent in the
Options and holders will not be entitled to participate in new issues of
capital offered to Shareholders during the currency of the Options
without exercising the Options.
11. Change in
exercise
price/Adjustment
for rights issue
An Option does not confer the right to a change in Exercise Price or
a change in the number of underlying securities over which the
Option can be exercised.
12. Transferability The Options are transferable subject to any restriction or escrow
arrangements imposed by ASX or under applicable Australian
securities laws.

Page | 18

Schedule 3 –Performance Rights Terms and Conditions

1. Entitlement Each Performance Right entitles the holder to subscribe for one Share upon
conversion of the Performance Right.
2. Plan The Performance Rights are granted under the Company's Employee Incentive
Performance Rights Plan (Plan).
Defined terms in these terms and conditions have the same meaning as in the
Plan. In the event of any inconsistency between the Plan and these terms and
conditions, these terms and conditions will apply to the extent of the
inconsistency.
3. Consideration Nil consideration is payable for the Performance Rights.
4. Expiry Date Each Performance Right will expire on the earlier to occur of:
(a)
the Performance Rights lapsing and being forfeited under the Plan; and
(b)
5:00 pm (WST) on:
CLASS
EXPIRY DATE
A
1 July 2025
B
1 July 2026
(Expiry Date).
For the avoidance of doubt, any unconverted Performance Rights will
automatically lapse on the Expiry Date.
5. Vesting Conditions The Performance Rights shall vest as follows:
CLASS
VESTING CONDITION
A
The holder remaining an employee of the Company from
the date of this letter until 1 July 2025.
B
The holder remaining an employee of the Company from
the date of this letter until 1 July 2026.
each, aVesting Condition.
6. Rights attaching to
Performance
Rights
Prior to a Performance Right being converted, the holder:
(a)
does not have any interest (legal, equitable or otherwise) in any Share
which may be issued on conversion of the Performance Right other than
as expressly set out in the Plan;
(b)
is not entitled to receive notice of, vote at or attend a meeting of the
shareholders of the Company;
(c)
is not entitled to receive any dividends declared by the Company; and
(d)
is not entitled to participate in any new issue of Shares (refer to section
17).
7. Restrictions on
dealing with
Performance
Rights
The Performance Rights cannot be sold, assigned, transferred, have a security
interest granted over or otherwise dealt with unless in Special Circumstances
under the Plan (including in the case of death or total or permanent disability of
the holder) with the consent of the Board.
A holder must not enter into any arrangement for the purpose of hedging their
economic exposure to a Performance Right that has been granted to them.
8. Cessation of
Employment
Other than where the Participant’s employment is ceased for fraudulent or
dishonest actions or breach of duties to the Company, on the termination or

Page | 19

cessation of the Participant’s employment, any unvested Performance Rights will
remain on foot and vest in the ordinary course, subject to the Board’s overriding
discretion to determine an alternate treatment.
9. Forfeiture
Conditions
Performance Rights will be forfeited in the following circumstances:
(d)
in the case of unvested Performance Rights only, where a Participant
acts fraudulently, dishonestly, negligently, in contravention of any Group policy or
wilfully breaches their duties to the Group;
(e)
where there is a failure to satisfy the Vesting Conditions in accordance
with the Plan;
(f)
on the date the Participant becomes insolvent, or their Nominated Party
(if applicable) becomes insolvent; or
(g)
on the Expiry Date,
subject to the discretion of the Board.
10. Conversion The Performance Rights can be converted at any time on and from the delivery
of a vesting notice until the Expiry Date (Conversion Period).
11. Conversion Notice The Performance Rights may be converted during the Conversion Period by
delivery of a written notice specifying the number of Performance Rights being
converted (Conversion Notice).
12. Timing of issue of
Shares and
quotation of Shares
on conversion
Within five Business Days after the issue of a Conversion Notice by the holder, the
Company will:
(a)
issue, allocate or cause to be transferred to the holder the number of
Shares to which the holder is entitled; and
(b)
if required, issue a substitute certificate for any remaining unconverted
Performance Rights held by the holder.
Additionally, the Company will do all such acts, matters and things to obtain the
grant of quotation of the Shares by ASX in accordance with the ASX Listing Rules
and subject to the expiry of any restriction period that applies to the Shares under
the Corporations Act or the ASX Listing Rules, as soon as reasonably practicable.
13. Cash Payment on
Conversion
On conversion of vested Performance Right the Participant (or their personal
representative) will be entitled to receive, at the absolute discretion of the Board,
either Shares or a Cash Payment.
14. Restrictions on
transfer of Shares
on conversion
Shares issued on conversion of the Performance Rights are subject to the following
restrictions:
(a)
if the Company is required but is unable to give ASX a notice that
complies with section 708A(5)(e) of the Corporations Act, Shares issued
on conversion of the Performance Rights may not be traded until 12
months after their issue unless the Company, at its sole discretion, elects
to issue a prospectus pursuant to section 708A(11) of the Corporations
Act;
(b)
all Shares issued on conversion of the Performance Rights are subject to
restrictions imposed by Applicable Law on dealing in Shares by persons
who possess material information likely to affect the value of the Shares
and which is not generally available; and
(c)
all Shares issued on conversion of the Performance Rights are subject to
the terms of the Company’s Securities Trading Policy as set out on the
Company’s website.
15. Rights attaching to
Shares on
conversion
Shares issued upon conversion of the Performance Rights will rank equally with the
then Shares of the Company.

Page | 20

16. Change of Control Subject at all times to the Listing Rules, if a Change of Control Event occurs (being
an event which results in any person (either alone or together with associates)
owning more than 50% of the Company’s issued capital), or the Board determines
that such an event is likely to occur, the Board may in its discretion determine the
manner in which any or all of the holder’s Performance Rights will be dealt with,
including, without limitation, in a manner that allows the holder to participate in
and/or benefit from any transaction arising from or in connection with the Change
of Control Event.
17. Participation in
new issues
Subject always to the rights under paragraphs 18 and 19, holders of Performance
Rights will not be entitled to participate in new issues of capital offered to holders
of Shares such as bonus issues and entitlement issues.
18. Adjustment for
bonus issue
If Shares are issued by the Company by way of bonus issue (other than an issue in
lieu of dividends or by way of dividend reinvestment), the holder of Performance
Rights is entitled, upon conversion of the Performance Rights, to receive an issue
of as many additional Shares as would have been issued to the holder if the holder
held Shares equal in number to the Shares in respect of which the Performance
Rights are converted.
19. Reorganisation If there is a reorganisation of the issued share capital of the Company (including
any subdivision, consolidation, reduction, return or cancellation of such issued
capital of the Company), the rights of each holder holding Performance Rights
will be changed to the extent necessary to comply with the ASX Listing Rules
applicable to a reorganisation of capital at the time of the reorganisation.
20. Employee Share
Trust
The Board uses an employee share trust for the purposes of holding Performance
Rights for holders under the Plan and delivering Shares on behalf of holders upon
conversion of Performance Rights. Further details of the Employee Share Trust are
set out in the Invitation.
21. Withholding Notwithstanding any other provision of these Rules, and without limiting the
amounts which may be deducted or withheld under Applicable Laws, if a
member of the Group, a trustee or the Plan administrator is obliged, or reasonably
believes that it may have an obligation to account for any Tax, or any
superannuation amounts (or equivalent social security contributions, if
applicable) in respect of a Participant (Withholding Amount), then that Group
company, trustee or Plan administrator (as applicable) is entitled to withhold or
be reimbursed by the Participant for the Withholding Amount payable or paid.

Page | 21

LODGE YOUR VOTE

ONLINEhttps://au.investorcentre.mpms.mufg.com

Buru Energy Limited ABN 71 130 651 437

BY MAIL  Buru Energy Limited C/- MUFG Corporate Markets (AU) Limited Locked Bag A14 Sydney South NSW 1235 Australia

BY FAX

+61 2 9287 0309

  • BY HAND MUFG Corporate Markets (AU) Limited Parramatta Square, Level 22, Tower 6, 10 Darcy Street, Parramatta NSW 2150

ALL ENQUIRIES TO Telephone: 1300 554 474 Overseas: +61 1300 554 474

X99999999999 X99999999999 PROXY FORM I/We being a member(s) of Buru Energy Limited and entitled to participate in and vote hereby appoint: APPOINT A PROXY the Chairman of the OR if you are NOT appointing the Chairman of the Meeting as your proxy, please write the name of the person or Meeting (mark box) body corporate you are appointing as your proxy or failing the person or body corporate named, or if no person or body corporate is named, the Chairman of the Meeting, as my/our proxy to act on my/our behalf (including to vote in accordance with the following directions or, if no directions have been given and to the extent permitted by the law, as the proxy sees fit) at the General Meeting of the Company to be held at 9:00am (AWST) on Tuesday, 18 November 2025 at The Park Business Centre, 45 Ventnor Avenue, West Perth WA 6005 (the Meeting ) and at any postponement or adjournment of the Meeting. Important for Resolutions 1, 2 & 3: If the Chairman of the Meeting is your proxy, either by appointment or by default, and you have not indicated your voting intention below, you expressly authorise the Chairman of the Meeting to exercise the proxy in respect of Resolutions 1, 2 & 3, even though the Resolutions are connected directly or indirectly with the remuneration of a member of the Company’s Key Management Personnel ( KMP ). The Chairman of the Meeting intends to vote undirected proxies in favour of each item of business. VOTING DIRECTIONS Proxies will only be valid and accepted by the Company if they are signed and received no later than 48 hours before the Meeting (that is, by no later than 9:00am (AWST) on Sunday, 16 November 2025). Please read the voting instructions overleaf before marking any boxes with an T Resolutions For Against Abstain * For Against Abstain * 1 Ratification of prior issue of 5 Approval to issue Options to

  • 1 Ratification of prior issue of Shares

  • 5 Approval to issue Options to Mr David Maxwell

==> picture [79 x 80] intentionally omitted <==

  • 2 Approval to issue Options to Placement Participants

  • 3 Approval to issue Options to SPP Participants

  • 4 Ratification of prior issue of incentive Performance Rights

 * If you mark the Abstain box for a particular Item, you are directing your proxy not to vote on your behalf on a show of hands or on a poll and your votes will not be counted in computing the required majority on a poll.

SIGNATURE OF SHAREHOLDERS – THIS MUST BE COMPLETED

Shareholder 1 (Individual) Joint Shareholder 2 (Individual) Joint Shareholder 3 (Individual) Sole Director and Sole Company Secretary Director/Company Secretary (Delete one) Director

This form should be signed by the shareholder. If a joint holding, either shareholder may sign. If signed by the shareholder’s attorney, the power of attorney must have been previously noted by the registry or a certified copy attached to this form. If executed by a company, the form must be executed in accordance with the company’s constitution and the Corporations Act 2001 (Cth).

BRU PRX2502C

HOW TO COMPLETE THIS SHAREHOLDER PROXY FORM

YOUR NAME AND ADDRESS

LODGEMENT OF A PROXY FORM

This is your name and address as it appears on the Company’s share register. If this information is incorrect, please make the correction on the form. Shareholders sponsored by a broker should advise their broker of any changes. Please note: you cannot change ownership of your shares using this form.

This Proxy Form (and any Power of Attorney under which it is signed) must be received at an address given below by 9:00am (AWST) on Sunday, 16 November 2025, being not later than 48 hours before the commencement of the Meeting. Any Proxy Form received after that time will not be valid for the scheduled Meeting.

APPOINTMENT OF PROXY

Proxy Forms may be lodged using the reply paid envelope or:

If you wish to appoint the Chairman of the Meeting as your proxy, mark the box in Step 1. If you wish to appoint someone other than the Chairman of the Meeting as your proxy, please write the name of that individual or body corporate in Step 1. A proxy need not be a shareholder of the Company.

ONLINE

https://au.investorcentre.mpms.mufg.com

Login to the Investor Centre using the holding details as shown on the Voting/Proxy Form. Select ‘Voting’ and follow the prompts to lodge your vote. To use the online lodgement facility, shareholders will need their “Holder Identifier” - Securityholder Reference Number (SRN) or Holder Identification Number (HIN).

DEFAULT TO CHAIRMAN OF THE MEETING

Any directed proxies that are not voted on a poll at the Meeting will default to the Chairman of the Meeting, who is required to vote those proxies as directed. Any undirected proxies that default to the Chairman of the BY MOBILE DEVICE Meeting will be voted according to the instructions set out in this Proxy Our voting website is designed specifically Form, including where the Resolutions are connected directly or indirectly for voting online. You can now lodge your with the remuneration of KMP. vote by scanning the QR code adjacent or VOTES ON ITEMS OF BUSINESS – PROXY APPOINTMENT enter the voting link You may direct your proxy how to vote by placing a mark in one of the https://au.investorcentre.mpms.mufg.com boxes opposite each item of business. All your shares will be voted in into your mobile device. Log in using the accordance with such a direction unless you indicate only a portion of Holder Identifier and postcode for your voting rights are to be voted on any item by inserting the percentage or shareholding. number of shares you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on the items of business, your proxy may vote as they choose If you mark more than one box on an item your vote on that item will be invalid. BY MAILAPPOINTMENT OF A SECOND PROXY Buru Energy Limited C/- MUFG Corporate Markets (AU) Limited You are entitled to appoint up to two persons as proxies to participate in the Meeting and vote on a poll. If you wish to appoint a second proxy, an Locked Bag A14 additional Proxy Form may be obtained by telephoning the Company’s Sydney South NSW 1235 share registry or you may copy this form and return them both together. Australia To appoint a second proxy you must:  BY FAX (a) on each of the first Proxy Form and the second Proxy Form state the +61 2 9287 0309 percentage of your voting rights or number of shares applicable to that form. If the appointments do not specify the percentage or number of  BY HAND votes that each proxy may exercise, each proxy may exercise half your votes. Fractions of votes will be disregarded; and Parramatta Square (b) return both forms together. Level 22, Tower 6 10 Darcy Street SIGNING INSTRUCTIONS Parramatta NSW 2150 You must sign this form as follows in the spaces provided: Individual: where the holding is in one name, the holder must sign. Joint Holding: where the holding is in more than one name, either shareholder may sign.

QR Code

Our voting website is designed specifically for voting online. You can now lodge your vote by scanning the QR code adjacent or enter the voting link https://au.investorcentre.mpms.mufg.com into your mobile device. Log in using the Holder Identifier and postcode for your shareholding.

To scan the code you will need a QR code reader application which can be downloaded for free on your mobile device.

Buru Energy Limited C/- MUFG Corporate Markets (AU) Limited

delivering it to MUFG Corporate Markets (AU) Limited* Parramatta Square Level 22, Tower 6 10 Darcy Street Parramatta NSW 2150

  • in business hours (Monday to Friday, 9:00am–5:00pm)

Power of Attorney: to sign under Power of Attorney, you must lodge the Power of Attorney with the registry. If you have not previously lodged this document for notation, please attach a certified photocopy of the Power of Attorney to this form when you return it.

Companies: where the company has a Sole Director who is also the Sole Company Secretary, this form must be signed by that person. If the company (pursuant to section 204A of the Corporations Act 2001 ) does not have a Company Secretary, a Sole Director can also sign alone. Otherwise this form must be signed by a Director jointly with either another Director or a Company Secretary. Please indicate the office held by signing in the appropriate place.

CORPORATE REPRESENTATIVES

If a representative of the corporation is to attend the Meeting the appropriate “Certificate of Appointment of Corporate Representative” must be received at [email protected] prior to admission in accordance with the Notice of General Meeting. A form of the certificate may be obtained from the Company’s share registry or online at www.mpms.mufg.com/en/mufg-corporate-markets.

IF YOU WOULD LIKE TO PARTICIPATE IN AND VOTE AT THE GENERAL MEETING, PLEASE BRING THIS FORM WITH YOU. THIS WILL ASSIST IN REGISTERING YOUR ATTENDANCE.